A novel role of SGLT2 inhibitors to increase circulating proangiogenic progenitor cells in patients with type 2 diabetes and cardiovascular disease: A sub-study of the EMPA-HEART CardioLink-6 Trial
Event:
ESC Congress 2019
Topic:
Microcirculation, Angiogenesis, Arteriogenesis
Session:
Insights into cardiac cell biology for repair and regeneration